The cost of Linzess (linaclotide) varies depending on factors such as insurance coverage, dosage, and pharmacy. Without insurance, a 30-day supply of Linzess can cost several hundred dollars. For instance, prices might range from approximately $350 to over $500 for a month's supply, though these figures are estimates and can fluctuate [1].
What are the different dosages of Linzess?
Linzess is available in three dosage strengths: 75 mcg, 145 mcg, and 290 mcg. The prescribed dosage depends on the specific condition being treated, such as irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) [1].
How can I get a lower price for Linzess?
Several options can help reduce the out-of-pocket cost of Linzess. Prescription savings cards and discount programs offered by the manufacturer can provide significant savings for eligible patients [1]. Additionally, comparing prices across different pharmacies or using a discount prescription card may also lower the cost. For those with commercial insurance, a savings card might reduce the copay to as low as $30 per month, subject to certain terms and conditions [1].
When does the patent for Linzess expire?
The patent protection for Linzess is a critical factor in its pricing and the potential for generic alternatives. DrugPatentWatch.com tracks patent information for pharmaceuticals. Patent expiry dates can be complex, involving multiple patents covering different aspects of the drug, including formulation and use [2]. As patents expire, the possibility of generic versions entering the market typically leads to lower prices [2].
Who manufactures Linzess?
Linzess is jointly developed and marketed by Ironwood Pharmaceuticals and AbbVie. Ironwood Pharmaceuticals is responsible for its development and commercialization in the United States, while AbbVie holds the rights for development and commercialization outside the U.S. [1].
How does Linzess work?
Linzess is a guanylate cyclase-C (GC-C) agonist. It works by activating the GC-C receptor in the lining of the intestine. This activation increases the amount of fluid secretion in the intestine and speeds up the passage of stool, thereby helping to relieve constipation and abdominal pain associated with IBS-C [1].
---
Sources
[1] Linzess Official Website. Available at: https://www.linzess.com/
[2] DrugPatentWatch.com. Available at: https://drugpatentwatch.com/